IMC Chicago’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.37M Sell
49,100
-151,900
-76% -$7.08M ﹤0.01% 2406
2025
Q4
$9.74M Buy
201,000
+155,400
+341% +$7.7M ﹤0.01% 1242
2025
Q3
$2.15M Buy
45,600
+21,100
+86% +$1.02M ﹤0.01% 2162
2025
Q2
$1.18M Buy
24,500
+9,000
+58% +$460K ﹤0.01% 2368
2025
Q1
$860K Sell
15,500
-10,000
-39% -$541K ﹤0.01% 2365
2024
Q4
$1.23M Sell
25,500
-1,400
-5% -$71.2K ﹤0.01% 2223
2024
Q3
$1.55M Buy
+26,900
New +$1.45M ﹤0.01% 1820

Other funds holding SNY

IMC Chicago's SNY Position: Q1 2026 in Review

IMC Chicago sold out of Sanofi (SNY) in Q1 2026, closing a stake of 68,037 shares — an estimated $3.17M sold.

IMC Chicago first reported a position in SNY in Q3 2024 and held it in 4 quarters. The position peaked at $3.3M in Q4 2025. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • IMC Chicago reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 68,037 Sanofi shares in Q1 2026, an estimated $3.17M.
  • IMC Chicago first reported a position in Sanofi in Q3 2024 and held it in 4 quarters.
  • IMC Chicago's Sanofi position peaked at $3.3M in Q4 2025.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.